Bharat Biotech to slow down production of Covaxin

The company said the decision has been taken as it has completed its supply obligations to procurement agencies and is foreseeing decrease in demand. The company will now focus on pending facility maintenance, process and facility optimization activities, it said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/39neOpR
via IFTTT